# Puma Biotechnology, Inc. (PBYI): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Puma Biotechnology, Inc. (PBYI) is 98/100, ranked against 24,000+ stocks in 35 markets (Quality 85, Value 57, Momentum 69, each scored against its sector).

- StockRank: 98/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 85, Value 57, Momentum 69: each a 0-100 percentile within the stock's sector.
- Position: #583 overall, #74 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 10.12 USD on 13 Oct 2026.
- Insider filings, last 180 days: directors sold USD 1.7M.

Source: https://moatmap.ai/stock/PBYI
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker